Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20230411005Phase 2Completed
A Phase 2 trial of capecitabine in Erythrodysesthesia syndrome (PPE), sponsored by Navamindradhiraj University Research Fund. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20230411005.